Pharmacies see Medicaid patients more frequently than any other healthcare touchpoint, creating opportunities for coverage loss early warning, exemption identification, and navigation access that work requirement implementation has entirely overlooked. A patient managing diabetes, hypertension, and depression might visit their pharmacy thirty-six times annually while seeing their doctor only six times. Ninety percent of Americans live within five miles of a community pharmacy, including rural areas where pharmacies may be the only healthcare presence. Extended hours accommodate working people who cannot access services during traditional business hours. Yet no state implementation framework has systematically incorporated pharmacies into work requirement navigation infrastructure.
The coverage loss early warning capability is unique to the pharmacy setting. When a pharmacist runs a prescription through the point-of-sale system, real-time eligibility verification returns coverage status within seconds. The pharmacist discovers coverage problems before the patient often knows, before the prescribing physician learns at the next appointment months away, and before the MCO’s care coordinator notices on enrollment reports. Starting December 2026, pharmacists will watch work requirement coverage losses play out at their pickup windows as patients who have filled insulin monthly for years suddenly show as ineligible.
This real-time knowledge could trigger intervention if systems were designed to enable it. A minimal intervention would train pharmacy staff to inform patients that coverage appears inactive and provide a card with navigation resources. A moderate intervention would have staff offer to call the navigation line with the patient immediately, facilitating connection rather than leaving independent follow-up. A robust intervention would station navigators at high-volume pharmacies during peak hours, catching patients at the moment of crisis when intervention is most effective. Each level requires different investment and generates different results, but none currently exists at scale.
The exemption trigger identification opportunity flows from what pharmacists already know about their patients. Medication profiles visible through prescription records often indicate conditions qualifying for work requirement exemptions. Someone filling clozapine is being treated for serious mental illness. Someone filling chemotherapy medications is undergoing cancer treatment. Someone on medication-assisted treatment for opioid use disorder is actively engaged in SUD treatment. Each medication profile suggests exemption eligibility that the patient may not recognize and that no one in the system is positioned to flag. Pharmacists could serve as screening points, identifying patients whose prescriptions suggest exemption eligibility and connecting them to documentation resources.
Medication Therapy Management encounters, which Medicaid programs already reimburse in many states, provide structured opportunities for work requirement counseling. During MTM sessions lasting 20 to 30 minutes, pharmacists review medication regimens, identify barriers to adherence, and develop medication plans. These encounters could incorporate work requirement status assessment alongside medication management, creating integrated support within existing reimbursement frameworks. If coverage loss threatens medication access, that threat is medication-related and falls naturally within MTM scope.
The operational barriers are real but not insurmountable. Pharmacies operate on thin margins and cannot absorb significant unreimbursed labor costs. If work requirement navigation takes fifteen minutes of pharmacist time per patient, someone must pay for that time. Chain versus independent pharmacy capacity creates different feasibility profiles: large chains could implement systemwide work requirement support through corporate decisions, while independent pharmacies have more flexibility to innovate but lack resources for sophisticated interventions. Pharmacist scope of practice varies by state and affects what pharmacists can do beyond providing information and referrals.
The business case for pharmacy participation exists even without reimbursement. Pharmacies benefit when patients maintain coverage because covered patients fill prescriptions generating revenue. Patients who lose Medicaid coverage often stop filling prescriptions entirely, eliminating revenue that would otherwise continue. Helping patients maintain coverage preserves the pharmacy’s customer base through an alignment of institutional interest and patient welfare.
The gap between pharmacy capacity and pharmacy utilization in work requirement implementation reflects a broader pattern: policy designed without considering where patients actually are. Work requirement navigation resources concentrate in government offices, community organizations, and healthcare facilities. Pharmacies, where Medicaid patients appear monthly with predictable regularity and where real-time eligibility data already flows through existing systems, remain outside the navigation infrastructure. States building work requirement implementation systems have an opportunity to leverage pharmacy touchpoints, but none of this will happen automatically. It requires intentional design, adequate reimbursement, and integration with broader navigation infrastructure that policy has not yet contemplated.
References: NACDS Community Pharmacy Access, 2024; Gallup Pharmacist Trust Survey, 2024; APhA Medication Therapy Management Services, 2024; CMS Medicaid Pharmacy Benefits, 2024; KFF Medicaid Prescription Drug Coverage, 2024; NABP State Pharmacy Practice Acts, 2024; HRSA Pharmacy Workforce Projections, 2024; Rural Health Info Hub Pharmacy Services, 2024.